1、White PaperNavigating Chinas MedTech Market Challenges,reforms,and opportunitiesZHEN NIE,Head of Med Devices,Global Consulting,IQVIA MedTech NANCY(SHUHUAI)JIN,Engagement Manager,Management Consulting,IQVIA ChinaTable of contentsIntroduction to Chinas MedTech market 1Mounting financial pressures on C

2、hinas public medical insurance 1Volume-based procurement:Expanding reach and impact 2Are cost-control measures reaching a“turning point”?2Embracing innovation to stay competitive in a changing market 3Private healthcare:A growing opportunity amid reform 3Turning regulatory uncertainty into long-term

3、 growth strategies 4The road ahead:How MedTech firms can thrive in Chinas market 5References 7About the authors 8 |1China has firmly established itself as the worlds second-largest medical device market,with high growth expectations globally.However,given the complexities of the local environment an

4、d the numerous challenges MedTech companies face,where do future opportunities lie?This IQVIA MedTech whitepaper explores the current state of Chinas MedTech market,examining the financial pressures,regulatory reforms,emerging opportunities,and providing insights into how MedTech companies can navig

5、ate this complex landscape.Mounting financial pressures on Chinas public medical insuranceIn recent years,Chinas total health expenditure has been rising due to the growing medical needs of its population.However,total health expenditure remains around 7%of GDP,still below the median level of OECD c

6、ountries.At the same time,the slowdown in economic growth has led to reduced income growth for the Basic Medical Insurance(BMI)fund.As the largest payer of health services in China,the National Healthcare Security Administration(NHSA)has implemented a series of reforms.These include Volume-Based Pro